APR 10, 2018 6:09 AM PDT

New Biomarker Improves Combination Cancer Therapy

WRITTEN BY: Kara Marker

Two anti-cancer drugs are better than one, and the discovery of a new biomarker will likely help researchers identify the appropriate timing for the administration of multiple treatments for cancer patients. From Osaka University and Elsevier, researchers show how a new biomarker helps scientists visualize blood vessel activity.

Cross section of a blood vessel. Source: Doc. RNDr. Josef Reischig, CSc

Drugs that inhibit angiogenesis, the formation of new blood vessels, are important in the fight against cancer because new blood vessels are required for cancer growth. “Adding an anti-angiogenic drug can boost an anticancer drug's effectiveness,” explained Nobuyuki Takakura, MD, PhD. “Basic research indicates that anti-angiogenic therapy allows the blood vessels to return to quiescence and "normalize" so that the anticancer drug can penetrate the tumor more effectively.”

Combination therapies such as the approach that Takakura describes could do wonders for the world of cancer treatment, if done right. Angiogenesis inhibitors, like vascular endothelial growth factor (VEGF) signaling can improve the effectiveness of anticancer drugs, like chemotherapy; most of the time, one drug can’t keep cancer in check all on its own. Researchers are hoping that by improving combination anti-cancer therapies, they can help cancer survivors live longer without relapse.

“However, it is unclear how we can recognize the 'window of opportunity' for the tumor vascular normalizing period for effective timing of anticancer drug treatment,” Takakura explained. “Therefore, biomarkers delineating this window are essential.”

Takakura’s research involves breaking down the difference between dormant and active proliferating vascular endothelial cells (ECs). The new biomarker, promoter activity of a particular DNA replication factor, was measured in ECs to do so. ECs form the lining of blood vessels and are important for supplying the tissues with blood.

Researchers saw no biomarker activity in normal adult skin vasculature, but ECs in and around tumor cells showed signs of activity, which was ultimately linked with tumor cell growth. Takakura said that this activity “may be utilized to visualize proliferating ECs.”

Non-proliferative ECs also express a cell surface protein called CD10, which Takakura also lists as a potential biomarker: "Since CD109 is highly expressed in dormant ECs, we suggest it can be used to detect normalized blood vessels, thus allowing identification of the 'window of opportunity' for optimal delivery of chemotherapeutics.”

The present study was published in the American Journal of Pathology.

Sources: Elsevier, Molecular Biology of the Cell, 4th Edition

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 17, 2020
Clinical & Molecular DX
Smartphone Cameras Detect Signs of Diabetes
AUG 17, 2020
Smartphone Cameras Detect Signs of Diabetes
In the future, detecting the early signs of diabetes could be as simple as picking up your smartphone. A new study, rece ...
AUG 18, 2020
Clinical & Molecular DX
DIY COVID Tests Instead of Vaccines?
AUG 18, 2020
DIY COVID Tests Instead of Vaccines?
Routine, do-it-yourself COVID-19 testing could be just as good as a vaccine when it comes to stopping the transmission o ...
SEP 12, 2020
Cardiology
Is Hyperuricemia an Indicator of Aortic Disease?
SEP 12, 2020
Is Hyperuricemia an Indicator of Aortic Disease?
Living in a culture of excess can have its benefits, but also its drawbacks. Diabetes is a common disease that is gettin ...
SEP 14, 2020
Health & Medicine
Direct Amplification: Rapid, Extraction-Free RT-qPCR Results
SEP 14, 2020
Direct Amplification: Rapid, Extraction-Free RT-qPCR Results
As the SARS-CoV-2 pandemic continues to rage across the United States and around the globe, the demand for COVID-19 test ...
OCT 22, 2020
Cardiology
Using Liposomes to Deliver Repair Packages to the Heart
OCT 22, 2020
Using Liposomes to Deliver Repair Packages to the Heart
The secret to any successful drug is not just its ability to treat a disease but its ability to target the disease exclu ...
NOV 05, 2020
Clinical & Molecular DX
Digging DEEP into Metabolomic Space
NOV 05, 2020
Digging DEEP into Metabolomic Space
Metabolomics is an umbrella term encompassing lipidomics and the study of smaller polar metabolites.  As such, more ...
Loading Comments...